Portfolio company
Pictura Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Presymptom Health
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
Nanocept
This company combines nanotechnology and diagnostics to enable early disease detection and support clinical decision-making for healthcare providers.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
SIME Clinical AI
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
